These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7460406)

  • 1. Slope analysis of plasma carcinoembryonic antigen levels in monitoring response to treatment in patients with metastatic carcinoma of the breast.
    Koch M; Paterson AH; McPherson TA
    Clin Oncol; 1980 Dec; 6(4):323-7. PubMed ID: 7460406
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carcinoma of the breast. Immunobiology and immunotherapy].
    Sega E; Castelli M; Sega FM
    Minerva Ginecol; 1982 Nov; 34(11):981-4. PubMed ID: 7155428
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological problems in radiotherapy and adjuvant cytostatic chemotherapy of breast cancer].
    Pusztai-Markos Z
    Fortschr Med; 1979 Mar; 97(11):487-93. PubMed ID: 369967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinoembryonic antigen in breast tumors: initial evaluation and monitoring].
    Bolla M; Daidj H; Lachet B; Bouchet Y; Vrousos C
    Bull Cancer; 1983; 70(4):300-2. PubMed ID: 6652251
    [No Abstract]   [Full Text] [Related]  

  • 5. [Has determination of carcinoembryonic antigen levels during follow-ups of patients with breast carcinoma proven to be of value?].
    Rammeloo T; Beunis MH; Postma T; Broodman CA
    Ned Tijdschr Geneeskd; 1987 Feb; 131(7):284-7. PubMed ID: 3561570
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunology of breast cancer: clinical implications.
    Black MM
    Prog Clin Cancer; 1975; 6():115-37. PubMed ID: 1105675
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring of a multi-modal schedule for the treatment of disseminated breast cancer.
    McIntosh IH; Bejrajati P; Goodfellow T; Palmer BV; Greening WP
    Dev Biol Stand; 1977 Apr 13-15; 38():471-6. PubMed ID: 344101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Specific immunotherapy in metastasizing breast cancer combined with chemotherapy. A prospective randomized study].
    Graninger W; Bettelheim P; Jakesz R; Rainer H; Moser K; Mörz R; Miksche M
    Acta Med Austriaca Suppl; 1979; 6():322-4. PubMed ID: 299220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen.
    Silva JS; Leight GS; Haagensen DE; Tallos PB; Cox EB; Dilley WG; Wells SA
    Cancer; 1982 Mar; 49(6):1236-42. PubMed ID: 6174201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carcinoembryonic antigen, a marker of cellular retrodifferentiation in breast carcinoma. Its role among the prognostic factors. Its integration into a coefficient of cell aggressiveness].
    Rabreau M; Saurel J; Larue-Charlus S; Morard JL; Decaudin C
    Arch Anat Cytol Pathol; 1986; 34(1):41-5. PubMed ID: 3015054
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of carcinoembryonic antigen test in human mammary carcinoma.
    Batabyal SK; Ghosh SN; Roy NK; Mehrotra YN; Gupta A
    Indian J Pathol Microbiol; 1987 Oct; 30(4):407-12. PubMed ID: 3507401
    [No Abstract]   [Full Text] [Related]  

  • 12. A correlation of erythrocyte sedimentation and plasma carcinoembryonic antigen in fibrocystic disease and carcinoma of the breast.
    Thynne GS; Greening WP
    Clin Oncol; 1980 Dec; 6(4):317-21. PubMed ID: 7460405
    [No Abstract]   [Full Text] [Related]  

  • 13. [Histological identification of carcinoembryonic antigen in breast cancer. Use of an immunohistochemical technique in 71 cases of breast cancer (author's transl)].
    Bonetti F; Maconi A; Pisa R; Menestrina F; Novelli P; Iannucci A; Chilosi M; Rasniewskij K
    Pathologica; 1981; 73(1026):639-47. PubMed ID: 6273781
    [No Abstract]   [Full Text] [Related]  

  • 14. [Carcinoembryonic antigen (CEA) and carcinoma of the breast].
    Catania G; Azzarello G; Di Stefano A; Cardì F; Basile F; Iuppa A; Mazzarino C
    Minerva Chir; 1982 Mar; 37(5):465-70. PubMed ID: 7088350
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prognostic significance of carcinoembryonic antigen and estrogen receptor in patients with breast carcinoma].
    Haase W
    Strahlenther Onkol; 1995 Mar; 171(3):179-80. PubMed ID: 7709337
    [No Abstract]   [Full Text] [Related]  

  • 16. Gastrointestinal metastasis to the breast.
    Madan AK; Ternovits C; Huber SA; Pei LA; Jaffe BM
    Surgery; 2002 Nov; 132(5):889-93. PubMed ID: 12464875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
    Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
    J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic significance of CEA in breast cancers].
    Percudani M; Dell'Anna B; Sianesi M
    Bull Cancer; 1982; 69(4):385. PubMed ID: 7150792
    [No Abstract]   [Full Text] [Related]  

  • 19. [Carcinoembryonic antigen in bone metastases. Diagnostic and prognostic value].
    Colson F; Gioud M; Bonvoisin B; Lejeune E; Bouvier M
    Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):621-5. PubMed ID: 6523014
    [No Abstract]   [Full Text] [Related]  

  • 20. [Systematic therapy of breast carcinoma: hormone therapy, immunotherapy, chemotherapy].
    Berta V; Perelli-Ercolini M; Beani G; Maino A
    Chir Ital; 1980 Dec; 32(6):1525-34. PubMed ID: 7249212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.